CD8A and melanoma: Similarly, a synergistic antitumor effect and improved curative responses were observed in B16F10‐ and BRAF‐mutated murine melanoma models with liposome‐based STING‐PD‐L1 combination therapy, emphasizing the critical role of “exhausted” tumor‐infiltrating CD8+ T cells in antitumor action.421